Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Liabilities and Shareholders Equity (2023 - 2025)

Historic Liabilities and Shareholders Equity for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $330.0 million.

  • Beta Bionics' Liabilities and Shareholders Equity changed N/A to $330.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 94297.16%. This contributed to the annual value of $149.6 million for FY2024, which is 3599.15% up from last year.
  • As of Q3 2025, Beta Bionics' Liabilities and Shareholders Equity stood at $330.0 million.
  • Over the past 5 years, Beta Bionics' Liabilities and Shareholders Equity peaked at $338.0 million during Q1 2025, and registered a low of $110.0 million during Q4 2023.
  • For the 3-year period, Beta Bionics' Liabilities and Shareholders Equity averaged around $251.5 million, with its median value being $330.0 million (2025).
  • Examining YoY changes over the last 5 years, Beta Bionics' Liabilities and Shareholders Equity showed a top increase of 3599.15% in 2024 and a maximum decrease of 3599.15% in 2024.
  • Quarter analysis of 3 years shows Beta Bionics' Liabilities and Shareholders Equity stood at $110.0 million in 2023, then skyrocketed by 35.99% to $149.6 million in 2024, then surged by 120.55% to $330.0 million in 2025.
  • Its Liabilities and Shareholders Equity was $330.0 million in Q3 2025, compared to $330.0 million in Q2 2025 and $338.0 million in Q1 2025.